Literature DB >> 16469677

Frozen section analysis of esophageal endoscopic mucosal resection specimens in the real-time management of Barrett's esophagus.

Ganapathy A Prasad1, Kenneth K Wang, Lori S Lutzke, Jason T Lewis, Schuyler O Sanderson, Navtej S Buttar, Louis M Wong Kee Song, Lynn S Borkenhagen, Lawrence J Burgart.   

Abstract

BACKGROUND & AIMS: The aim of this study was to assess the validity of frozen section analysis of endoscopic mucosal resection (EMR) specimens from Barrett's esophagus as compared with permanent sections for the detection of neoplasia. Frozen sections help to give immediate feedback for surgical procedures. It has not been determined whether EMR can be adequately interpreted by using frozen sections to aid endoscopists in completely resecting neoplastic lesions.
METHODS: EMR specimens from Barrett's esophagus with high-grade dysplasia (HGD) and/or carcinoma were tested by frozen section. Pathologists evaluated EMR specimens for the depth of invasion as well as the appearance of clear margins of resection. The kappa statistic was calculated to assess the degree of agreement between the frozen section and permanent section diagnoses.
RESULTS: Twenty-three consecutive patients underwent 30 EMRs with frozen section diagnosis. Frozen section revealed a carcinoma in 7 specimens (23%) and dysplasia in 20 (66%). Permanent sections found carcinoma in 8 specimens (26%), dysplasia in 19 specimens (63%), and normal or nondysplastic Barrett's esophagus in the remainder. The kappa statistic for the depth of invasion of EMR specimens was 0.93 (near perfect agreement). The kappa statistic for the margins of the EMR specimens was 0.80 (excellent agreement).
CONCLUSIONS: This study indicated that frozen section analysis of esophageal EMR specimens is valid as compared with permanent section. This technique might allow rapid evaluation about the degree and depth of involvement of cancers. This allows physicians to make decisions regarding further therapy if margins are involved or decrease the use of EMR for histologically benign-appearing lesions.

Entities:  

Mesh:

Year:  2006        PMID: 16469677      PMCID: PMC2635090          DOI: 10.1016/j.cgh.2005.11.002

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  20 in total

Review 1.  Surgical therapy of oesophageal carcinoma.

Authors:  J M Müller; H Erasmi; M Stelzner; U Zieren; H Pichlmaier
Journal:  Br J Surg       Date:  1990-08       Impact factor: 6.939

2.  Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy.

Authors:  J J Nigro; J A Hagen; T R DeMeester; S R DeMeester; J H Peters; S Oberg; J Theisen; M Kiyabu; P F Crookes; C G Bremner
Journal:  J Thorac Cardiovasc Surg       Date:  1999-01       Impact factor: 5.209

3.  Outcome of endoscopic mucosal resection for early gastric cancer: review of the Japanese literature.

Authors:  T Kojima; A Parra-Blanco; H Takahashi; R Fujita
Journal:  Gastrointest Endosc       Date:  1998-11       Impact factor: 9.427

4.  Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan.

Authors:  M Kodama; T Kakegawa
Journal:  Surgery       Date:  1998-04       Impact factor: 3.982

Review 5.  [Endoscopic mucosal resection for early esophageal cancer].

Authors:  M Inoue; H Shiozaki; S Tamura; M Monden
Journal:  Nihon Rinsho       Date:  1996-05

6.  Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions.

Authors:  H Inoue; K Takeshita; H Hori; Y Muraoka; H Yoneshima; M Endo
Journal:  Gastrointest Endosc       Date:  1993 Jan-Feb       Impact factor: 9.427

7.  A new method of endoscopic mucosal resection of neoplastic lesions in the stomach: its technical features and results.

Authors:  K Takeshita; M Tani; H Inoue; I Saeki; T Honda; F Kando; N Saito; M Endo
Journal:  Hepatogastroenterology       Date:  1997 Nov-Dec

8.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States.

Authors:  S S Devesa; W J Blot; J F Fraumeni
Journal:  Cancer       Date:  1998-11-15       Impact factor: 6.860

9.  Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus.

Authors:  Rodney J Pacifico; Kenneth K Wang; Louis-Michel Wongkeesong; Navtej S Buttar; Lori S Lutzke
Journal:  Clin Gastroenterol Hepatol       Date:  2003-07       Impact factor: 11.382

10.  Transhiatal esophagectomy for benign and malignant disease.

Authors:  M B Orringer; B Marshall; M C Stirling
Journal:  J Thorac Cardiovasc Surg       Date:  1993-02       Impact factor: 5.209

View more
  8 in total

1.  Esophageal adenocarcinoma.

Authors:  Kenneth K Wang
Journal:  Clin Gastroenterol Hepatol       Date:  2006-09-18       Impact factor: 11.382

2.  Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus.

Authors:  Ganapathy A Prasad; Kenneth K Wang; Navtej S Buttar; Louis-Michel Wongkeesong; Kausilia K Krishnadath; Francis C Nichols; Lori S Lutzke; Lynn S Borkenhagen
Journal:  Gastroenterology       Date:  2007-02-07       Impact factor: 22.682

3.  Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus.

Authors:  Ganapathy A Prasad; Kenneth K Wang; Kevin C Halling; Navtej S Buttar; Louis-Michel Wongkeesong; Alan R Zinsmeister; Shannon M Brankley; Emily G Barr Fritcher; Wytske M Westra; Kausilia K Krishnadath; Lori S Lutzke; Lynn S Borkenhagen
Journal:  Gastroenterology       Date:  2008-05-07       Impact factor: 22.682

Review 4.  Endoscopic mucosal resection in the management of esophageal neoplasia: current status and future directions.

Authors:  Vikneswaran Namasivayam; Kenneth K Wang; Ganapathy A Prasad
Journal:  Clin Gastroenterol Hepatol       Date:  2010-06-10       Impact factor: 11.382

5.  Depth of submucosal invasion does not predict lymph node metastasis and survival of patients with esophageal carcinoma.

Authors:  Rami J Badreddine; Ganapathy A Prasad; Jason T Lewis; Lori S Lutzke; Lynn S Borkenhagen; Kelly T Dunagan; Kenneth K Wang
Journal:  Clin Gastroenterol Hepatol       Date:  2009-11-27       Impact factor: 11.382

6.  Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus.

Authors:  Ganapathy A Prasad; Navtej S Buttar; Louis M Wongkeesong; Jason T Lewis; Schuyler O Sanderson; Lori S Lutzke; Lynn S Borkenhagen; Kenneth K Wang
Journal:  Am J Gastroenterol       Date:  2007-07-19       Impact factor: 10.864

7.  Correlation of histology with biomarker status after photodynamic therapy in Barrett esophagus.

Authors:  Ganapathy A Prasad; Kenneth K Wang; Kevin C Halling; Navtej S Buttar; Louis-Michel Wongkeesong; Alan R Zinsmeister; Shannon M Brankley; Wytske M Westra; Lori S Lutzke; Lynn S Borkenhagen; Kelly Dunagan
Journal:  Cancer       Date:  2008-08-01       Impact factor: 6.860

8.  Preoperative endoscopic titanium clip placement facilitates intraoperative localization of early-stage esophageal cancer or severe dysplasia.

Authors:  Lei Tan; Juan Feng; Qin Zhao; Ping Chen; Guotao Yang
Journal:  World J Surg Oncol       Date:  2017-08-02       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.